Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853, USA.
ChemMedChem. 2023 Jun 15;18(12):e202300106. doi: 10.1002/cmdc.202300106. Epub 2023 Apr 21.
The mitochondrial calcium uniporter (MCU) is a transmembrane protein that is responsible for mediating mitochondrial calcium (mCa ) uptake. Given this critical function, the MCU has been implicated as an important target for addressing various human diseases. As such, there has a been growing interest in developing small molecules that can inhibit this protein. To date, metal coordination complexes, particularly multinuclear ruthenium complexes, are the most widely investigated MCU inhibitors due to both their potent inhibitory activities as well as their longstanding use for this application. Recent efforts have expanded the metal-based toolkit for MCU inhibition. This concept paper summarizes the development of new metal-based inhibitors of the MCU and their structure-activity relationships in the context of improving their potential for therapeutic use in managing human diseases related to mCa dysregulation.
线粒体钙单向转运蛋白(MCU)是一种跨膜蛋白,负责介导线粒体钙(mCa )摄取。鉴于其关键功能,MCU 已被认为是解决各种人类疾病的重要靶点。因此,人们越来越感兴趣开发可以抑制这种蛋白质的小分子。迄今为止,金属配位化合物,特别是多核钌配合物,由于其强大的抑制活性以及在该应用中的长期使用,是研究最多的 MCU 抑制剂。最近的研究工作扩展了用于 MCU 抑制的基于金属的工具包。本文概念总结了新型基于金属的 MCU 抑制剂的开发及其在改善其用于治疗与 mCa 失调相关的人类疾病的潜在用途方面的结构-活性关系。